Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, January 17, 2018
Pharmaceutical Product Development and Quotient Sciences announced a new collaboration to accelerate pediatric drug development.
read more
PPS announced the Grand Opening of a new wing at the Riverview site dedicated to the production of HPAPIs with low Occupational Exposure Levels.
read more
Wednesday, October 11, 2017
Praxis Packaging Solutions has selected TraceLink to help its pharmaceutical manufacturing customers comply with the serialization deadline for the DSCSA.
read more
Precigen announced the official opening of its new manufacturing facility.
read more
Precision NanoSystems (PNI), a global leader in innovative solutions for genetic medicine development, will expand its global headquarters with a 75,000-square-foot facility currently under construction. Slated for completion in Q4 2022, the new site...
read more
Premier Pharmacy Labs is voluntarily recalling all unexpired products, intended to be sterile, due to a lack of sterility assurance.
read more
Wednesday, October 16, 2019
Prevail Therapeutics and Lonza announced the companies have entered into a strategic collaboration.
read more
Friday, December 01, 2017
Prime Therapeutics and Biogen have partnered on an outcomes-based contract for several MS drugs as part of Prime's CareCentered Contract program.
read more
Dr. Havranek-Kosicek, previously Director of Finance and Control for the DSM Pharma Chemicals business unit of DSM Pharmaceutical Products, the pharmaceutical contract manufacturing and technology organization of Royal DSM N.V. (NYSE, Euronext: DSM ...
read more
ProBioGen and Minapharm Pharmaceuticals announce the incorporation of ProBioGen's subsidiary "MiGenTra" with headquarters in Berlin and access to a site in Cairo, which will house its principal manufacturing plant. MiGenTra will enhance the ...
read more
Monday, February 14, 2022
ProBioGen has announced a multi-product commercial license agreement with AstraZeneca to use the GlymaxX technology. Following evaluation of the technology under a research license, AstraZeneca will now continue to use GlymaxX and will integrate the ...
read more
ProBioGen has signed a second clinical immuno-oncology development and manufacturing agreement with Tizona Therapeutics, a privately held immunology company.
read more
Wednesday, August 17, 2022
ProBioGen closed a Master Service Agreement with NextPoint and initiated development and GMP manufacturing of their lead antibody candidate.
read more
ProBioGen AG and Pionyr Immunotherapeutics have announced a second service and license agreement to develop novel antibody therapeutics.
read more
Thursday, October 24, 2013
The loss of drug product during the filtration and fill process presents a major challenge to pharmaceutical and biologics manufacturers worldwide. For Cobra Biologics, a leading CMO providing aseptic manufacture for clinical and commercial supply, ...
read more